International donor support for fighting HIV has flat-lined, yet the United States--the world's largest donor--is under fire from the global community, and domestic political support for Obama administration global health funding is flagging, writes CFR's Laurie Garrett.
The global fight against HIV and AIDS cannot be won without success in South Africa, but while President Zuma's government has made progress, it has to do more to prevent future infections and provide better treatment, says CFR's Peter Navario.
Speaker: Andrew Witty Presider: Vijay V. Vaitheeswaran
Andrew Witty, Chief Executive Officer of Glaxosmithkline, speaks about innovative and economically sustainable new ways to ensure pharmaceutical access to populations in the developing world. This meeting is part of the CEO speaker series which aims to educate the CFR membership on the private sector's important role in the policy debate by engaging the global business community's top leadership. Members benefit from hearing CEOs' perspectives as well as interacting with them in an informal setting; in turn, CEOs have the opportunity to highlight the work of their organization and strengthen their relationship with CFR.
This Working Paper, a contribution to the aids2031 project, focuses on the future of donor financing for HIV prevention and treatment programs and makes recommendations for what the donor community and national governments can do now to build a foundation that ensures steady, long-term funding for HIV/AIDS and alleviates the impact of future challenges.
Learn more about CFR’s mission and its work over the past year in the 2016 Annual Report. The Annual Report spotlights new initiatives, high-profile events, and authoritative scholarship from CFR experts, and includes a message from CFR President Richard N. Haass. Read and download »